Phcog.Net logo
Submit

BROWSE ALL JOURNALS

    SEE ALL 6 JOURNALS
    Pharmacognosy MagazineNOW IN
    Article

    Juglanin Attenuated Adjuvant‑Induced Arthritis via Inactivating NF‑κB/IκBα and A Disintegrin‑Like and Metalloproteinase Domain with Thrombospondin‑1 Repeat Pathways in Experimental Rats

    Chao Ning1, Shaoqi Ning2, Heng Luo3, Lei Yan4★★ Corresponding author

    1. 1College of Stomatology, Xi’an Jiaotong University, China.
    2. 2Institute for Communicable Disease Control and Prevention of Shaanxi Provincial Centre for Disease Control and Prevention, Xi’an, China.
    3. 3Reproductive Medicine Center, Tangdu Hospital, Fourth Military Medical University, Xinsi Road, Baqiao District, China.
    4. 4Clinical Experimental Centre, Xi’an International Medical Center Hospital, Xitai Road, High-tech Zone, Xi’an, Shaanxi Province, China.

    CORRESPONDENCE

    Lei Yan

    Clinical Experimental Centre, Xi’an International Medical Center Hospital, Xitai Road, High-tech Zone, Xi’an, Shaanxi Province, China.

    yanlei1028@163.com

    Received: 22-03-2020; Revised: 20-04-2020; Accepted: 28-08-2020.

    Volume 16, Issue 72 · pp. 803–811 · PUBLISHED 16 February 2021 · DOI: 10.4103/pm.pm_106_20

    View on Pharmacogn. Mag. original site ↗

    ABSTRACT

    Objective: The present study was undertaken to evaluate their possible mechanism of action against adjuvant‑induced arthritis (AIA), i.e., Freund’s complete adjuvant (FCA)‑induced arthritis, in experimental rats. Materials and Methods: FCA (0.1 mL) was administered into the subplantar region of female Wistar rats paw to induced AIA. The rats were treated with vehicle (distilled water, 10 mL/kg) or leflunomide (10 mg/kg), or juglanin (10, 20, and 40 mg/kg, respectively) orally for the next 16 days. Various biochemical, molecular, and histological parameters were evaluated to determine the potential of juglanin. Results: Subplantar administration of FCA resulted in a statistically significant (P < 0.05) induction of AIA reflected by alteration in paw volume, joint diameter, paw withdrawal threshold, and paw withdrawal latency, which was statistically significantly inhibited (P < 0.05) by juglanin (20 and 40 mg/kg). It also statistically significantly attenuated (P < 0.05) FCA‑induced elevated hepatic oxido‑nitrosative stress and mRNA expressions of tumor necrosis factor‑alpha (TNF‑α), interleukin (IL) IL‑1β, IL‑6, transforming growth factor‑beta (TGF‑β), cyclooxygenase‑2 (COX‑2), and inducible nitric oxide synthase (iNOs). Western blot analysis revealed that juglanin statistically significantly downregulated (P < 0.05) protein expressions of NF‑κB, IκBα, a disintegrin‑like and metalloproteinase domain with thrombospondin‑1 repeats (ADAMTS)‑4, and ADAMTS‑5 in hepatic tissue. It also statistically significantly attenuated (P < 0.05) histopathological anomalies induced in the tibiotarsal joint. Conclusion: The present communication suggests that juglanin attenuated altered mechano‑tactile allodynia and hyperalgesia via inhibition of elevated oxido‑nitrosative stress, cytokines (TNF‑α and ILs) levels, immune‑inflammatory (TGF‑β, NF‑κB, Ikβα, COX‑2, and iNOs) mediators, and ADAMTS, thus exerting its anti‑arthritic potential.

    KEYWORDS

    Open in new tab

    REFERENCES

    As published

    Showing references and in-text citations exactly as published.

      Cite this article

      SELECT FORMAT

      Ning, C., Ning, S., Luo, H., & Yan, L. (2021). Juglanin Attenuated Adjuvant‑Induced Arthritis via Inactivating NF‑κB/IκBα and A Disintegrin‑Like and Metalloproteinase Domain with Thrombospondin‑1 Repeat Pathways in Experimental Rats. Pharmacognosy Magazine, 16(72), 803–811. https://doi.org/10.4103/pm.pm_106_20